Rank | Gene Set | Z-score |
---|---|---|
1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.86529720 |
2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.86529720 |
3 | modulation by symbiont of host immune response (GO:0052553) | 5.86529720 |
4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.86529720 |
5 | modulation by symbiont of host defense response (GO:0052031) | 5.86529720 |
6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.86529720 |
7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.66386835 |
8 | neutrophil activation involved in immune response (GO:0002283) | 5.14289841 |
9 | oligosaccharide catabolic process (GO:0009313) | 5.13286060 |
10 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.67545877 |
11 | iron ion import (GO:0097286) | 4.14056130 |
12 | ceramide catabolic process (GO:0046514) | 4.10365855 |
13 | macrophage activation involved in immune response (GO:0002281) | 4.10172634 |
14 | glucocorticoid biosynthetic process (GO:0006704) | 3.97437192 |
15 | positive regulation of interferon-alpha production (GO:0032727) | 3.95928258 |
16 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.91569534 |
17 | C21-steroid hormone biosynthetic process (GO:0006700) | 3.83194995 |
18 | response to peptidoglycan (GO:0032494) | 3.73902262 |
19 | regulation of interferon-alpha production (GO:0032647) | 3.73242259 |
20 | wound healing, spreading of epidermal cells (GO:0035313) | 3.71638091 |
21 | protein localization to endosome (GO:0036010) | 3.70261129 |
22 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.70038259 |
23 | response to host immune response (GO:0052572) | 3.70038259 |
24 | immunoglobulin mediated immune response (GO:0016064) | 3.66232684 |
25 | amino sugar catabolic process (GO:0046348) | 3.63594306 |
26 | microglial cell activation (GO:0001774) | 3.62127938 |
27 | respiratory burst (GO:0045730) | 3.61398162 |
28 | negative regulation of interleukin-12 production (GO:0032695) | 3.59978642 |
29 | neutrophil activation (GO:0042119) | 3.50950622 |
30 | estrogen biosynthetic process (GO:0006703) | 3.47696032 |
31 | granulocyte activation (GO:0036230) | 3.47627676 |
32 | progesterone metabolic process (GO:0042448) | 3.40447634 |
33 | pinocytosis (GO:0006907) | 3.39196949 |
34 | cellular response to interferon-alpha (GO:0035457) | 3.38855505 |
35 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.38297899 |
36 | response to host (GO:0075136) | 3.38297899 |
37 | response to host defenses (GO:0052200) | 3.38297899 |
38 | negative regulation of mast cell activation (GO:0033004) | 3.38101689 |
39 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.35743115 |
40 | natural killer cell mediated immunity (GO:0002228) | 3.35743115 |
41 | keratan sulfate catabolic process (GO:0042340) | 3.31882759 |
42 | membrane lipid catabolic process (GO:0046466) | 3.29052055 |
43 | sphingolipid catabolic process (GO:0030149) | 3.27776386 |
44 | phagocytosis, recognition (GO:0006910) | 3.24854843 |
45 | glucocorticoid metabolic process (GO:0008211) | 3.23527143 |
46 | regulation of mononuclear cell migration (GO:0071675) | 3.20810385 |
47 | myeloid cell activation involved in immune response (GO:0002275) | 3.17234502 |
48 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.15679206 |
49 | low-density lipoprotein particle clearance (GO:0034383) | 3.15614962 |
50 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.11335002 |
51 | response to lipoprotein particle (GO:0055094) | 3.10585957 |
52 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.10283899 |
53 | negative regulation of cell killing (GO:0031342) | 3.10283899 |
54 | macrophage activation (GO:0042116) | 3.10214063 |
55 | osteoclast differentiation (GO:0030316) | 3.09372266 |
56 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.09079228 |
57 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.06678324 |
58 | I-kappaB phosphorylation (GO:0007252) | 3.06006979 |
59 | detection of external biotic stimulus (GO:0098581) | 2.98751807 |
60 | detection of molecule of bacterial origin (GO:0032490) | 2.98262330 |
61 | regulation of mast cell degranulation (GO:0043304) | 2.97834478 |
62 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.94987755 |
63 | peptide catabolic process (GO:0043171) | 2.94726761 |
64 | B cell mediated immunity (GO:0019724) | 2.93686843 |
65 | superoxide anion generation (GO:0042554) | 2.93230704 |
66 | positive regulation of macrophage differentiation (GO:0045651) | 2.92630212 |
67 | sphingosine metabolic process (GO:0006670) | 2.91821123 |
68 | positive regulation of interferon-beta production (GO:0032728) | 2.91602662 |
69 | regulation of mast cell activation (GO:0033003) | 2.91020927 |
70 | negative regulation of lipid storage (GO:0010888) | 2.87320053 |
71 | cellular response to cadmium ion (GO:0071276) | 2.87031123 |
72 | response to muramyl dipeptide (GO:0032495) | 2.86624807 |
73 | wound healing, spreading of cells (GO:0044319) | 2.85868926 |
74 | leukocyte mediated cytotoxicity (GO:0001909) | 2.85758000 |
75 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.85392480 |
76 | positive regulation of antigen processing and presentation (GO:0002579) | 2.85335491 |
77 | N-acetylneuraminate metabolic process (GO:0006054) | 2.83475873 |
78 | positive regulation of mast cell activation (GO:0033005) | 2.82708998 |
79 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.81164514 |
80 | neutrophil mediated immunity (GO:0002446) | 2.80885854 |
81 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.78234281 |
82 | apoptotic cell clearance (GO:0043277) | 2.77327234 |
83 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.76451580 |
84 | membrane raft organization (GO:0031579) | 2.75454761 |
85 | response to thyroid hormone (GO:0097066) | 2.75375576 |
86 | C21-steroid hormone metabolic process (GO:0008207) | 2.74168342 |
87 | cellular response to zinc ion (GO:0071294) | 2.73509126 |
88 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.72878535 |
89 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.71360607 |
90 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.70751496 |
91 | glycosphingolipid catabolic process (GO:0046479) | 2.70417391 |
92 | T-helper 1 type immune response (GO:0042088) | 2.70267679 |
93 | response to interferon-alpha (GO:0035455) | 2.69949171 |
94 | cellular extravasation (GO:0045123) | 2.68822361 |
95 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.67999553 |
96 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.67988998 |
97 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.66846941 |
98 | phagocytosis, engulfment (GO:0006911) | 2.65287954 |
99 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.64731645 |
100 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.63662617 |
101 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.63172211 |
102 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.62726796 |
103 | adhesion of symbiont to host (GO:0044406) | 2.59185217 |
104 | response to follicle-stimulating hormone (GO:0032354) | 2.58958433 |
105 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.58479785 |
106 | cellular response to antibiotic (GO:0071236) | 2.57613208 |
107 | hyaluronan catabolic process (GO:0030214) | 2.57399728 |
108 | regulation of leukocyte degranulation (GO:0043300) | 2.57143251 |
109 | eosinophil chemotaxis (GO:0048245) | 2.56743618 |
110 | myeloid cell homeostasis (GO:0002262) | 2.56002595 |
111 | detection of other organism (GO:0098543) | 2.54319459 |
112 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.54238672 |
113 | regulation of antigen processing and presentation (GO:0002577) | 2.54143639 |
114 | cytokine metabolic process (GO:0042107) | 2.53437701 |
115 | detection of biotic stimulus (GO:0009595) | 2.52467455 |
116 | diol metabolic process (GO:0034311) | 2.51468555 |
117 | positive regulation of macrophage cytokine production (GO:0060907) | 2.51296782 |
118 | surfactant homeostasis (GO:0043129) | 2.50978046 |
119 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.50182845 |
120 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.49665257 |
121 | positive regulation of mast cell degranulation (GO:0043306) | 2.49665257 |
122 | myeloid leukocyte activation (GO:0002274) | 2.49483145 |
123 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.49143968 |
124 | positive regulation of leukocyte degranulation (GO:0043302) | 2.46672288 |
125 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.46580778 |
126 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.46369733 |
127 | lymphocyte mediated immunity (GO:0002449) | 2.45248175 |
128 | sphingoid metabolic process (GO:0046519) | 2.44690572 |
129 | cell adhesion mediated by integrin (GO:0033627) | 2.44518443 |
130 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.43147966 |
131 | positive regulation of interleukin-6 production (GO:0032755) | 2.43132281 |
132 | cellular response to ethanol (GO:0071361) | 2.42913876 |
133 | positive regulation of chemokine production (GO:0032722) | 2.42372937 |
134 | regulation of monocyte chemotaxis (GO:0090025) | 2.41954872 |
135 | negative regulation of interleukin-17 production (GO:0032700) | 2.41793623 |
136 | leukocyte aggregation (GO:0070486) | 2.40119662 |
137 | intracellular pH reduction (GO:0051452) | 2.39077248 |
138 | glycolipid catabolic process (GO:0019377) | 2.37430580 |
139 | vitamin D metabolic process (GO:0042359) | 2.37145388 |
140 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.37089532 |
141 | myeloid dendritic cell differentiation (GO:0043011) | 2.36980153 |
142 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.36979712 |
143 | regulation of cholesterol storage (GO:0010885) | 2.36488007 |
144 | glucosamine-containing compound catabolic process (GO:1901072) | 2.36418561 |
145 | intracellular lipid transport (GO:0032365) | 2.36128485 |
146 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.35979135 |
147 | myeloid dendritic cell activation (GO:0001773) | 2.34275581 |
148 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.33619046 |
149 | plasma lipoprotein particle clearance (GO:0034381) | 2.33254944 |
150 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.33108177 |
151 | cellular response to gonadotropin stimulus (GO:0071371) | 2.33009129 |
152 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.30870832 |
153 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.30835908 |
154 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.30311000 |
155 | androgen biosynthetic process (GO:0006702) | 2.29817056 |
156 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.26587744 |
157 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.25110817 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.68613557 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.01933425 |
3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.98043525 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.81378831 |
5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.27606353 |
6 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.78414678 |
7 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.62790752 |
8 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.60777352 |
9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.35731290 |
10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.17631840 |
11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.97277584 |
12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.89730620 |
13 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.80249312 |
14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.74008948 |
15 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.62749699 |
16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.57599107 |
17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.41420732 |
18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.38963756 |
19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.35397950 |
20 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.31690693 |
21 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.31311244 |
22 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.25280545 |
23 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.18341131 |
24 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.14001816 |
25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.13817556 |
26 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.12036874 |
27 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.11856558 |
28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.02924387 |
29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.94368182 |
30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.91592630 |
31 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.71458082 |
32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.68877080 |
33 | MYB_26560356_Chip-Seq_TH2_Human | 1.67711794 |
34 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.66643574 |
35 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.66232700 |
36 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.64494169 |
37 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.62200583 |
38 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.60957430 |
39 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.58768158 |
40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.55032999 |
41 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.54491286 |
42 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.49311393 |
43 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.47760494 |
44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.47641508 |
45 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.46666771 |
46 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43316122 |
47 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.38360039 |
48 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.37153032 |
49 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.37153032 |
50 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36539046 |
51 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.35534522 |
52 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.34069268 |
53 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.33494393 |
54 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.30188548 |
55 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.29900355 |
56 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28273781 |
57 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26623240 |
58 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.24518619 |
59 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.24518619 |
60 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.24440868 |
61 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23428637 |
62 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.23243655 |
63 | MYB_26560356_Chip-Seq_TH1_Human | 1.22352540 |
64 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.21501649 |
65 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.20650747 |
66 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.19983409 |
67 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.19492630 |
68 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.19470850 |
69 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15972154 |
70 | * MAF_26560356_Chip-Seq_TH1_Human | 1.15409883 |
71 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.14448393 |
72 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14424922 |
73 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.14180991 |
74 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13461652 |
75 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.12764644 |
76 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.12643117 |
77 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.11132998 |
78 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.10135534 |
79 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09165609 |
80 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.08821579 |
81 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.07634250 |
82 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05974191 |
83 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.05455338 |
84 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05103643 |
85 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.04770201 |
86 | CJUN_26792858_Chip-Seq_BT549_Human | 1.04199779 |
87 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.04185670 |
88 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.03660984 |
89 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.03615859 |
90 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.99387306 |
91 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.98955094 |
92 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98267047 |
93 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.97450824 |
94 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.95803955 |
95 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95328198 |
96 | TP53_16413492_ChIP-PET_HCT116_Human | 0.94661643 |
97 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94315354 |
98 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94087387 |
99 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.93827007 |
100 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92062322 |
101 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.91813928 |
102 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.91435034 |
103 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.91135038 |
104 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.90246321 |
105 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.89833736 |
106 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.88796147 |
107 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87943641 |
108 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.87845265 |
109 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.86924589 |
110 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.86580978 |
111 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.86202329 |
112 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.84819665 |
113 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.84730652 |
114 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.84490375 |
115 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.83424799 |
116 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.83391053 |
117 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.83340945 |
118 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83338470 |
119 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.83291776 |
120 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83273758 |
121 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.83139989 |
122 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.81696229 |
123 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81083206 |
124 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80440454 |
125 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80365444 |
126 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79373610 |
127 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77684767 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005058_abnormal_lysosome_morphology | 3.57695783 |
2 | MP0009840_abnormal_foam_cell | 3.45740759 |
3 | MP0000569_abnormal_digit_pigmentation | 3.34065347 |
4 | MP0001835_abnormal_antigen_presentation | 3.14910200 |
5 | MP0003436_decreased_susceptibility_to | 2.74928458 |
6 | MP0002419_abnormal_innate_immunity | 2.48464223 |
7 | MP0003172_abnormal_lysosome_physiology | 2.43381768 |
8 | MP0000604_amyloidosis | 2.30424935 |
9 | MP0003303_peritoneal_inflammation | 2.29166927 |
10 | MP0001958_emphysema | 2.27163838 |
11 | MP0008438_abnormal_cutaneous_collagen | 2.26069197 |
12 | MP0004782_abnormal_surfactant_physiolog | 2.24832564 |
13 | MP0005257_abnormal_intraocular_pressure | 2.22205708 |
14 | MP0002148_abnormal_hypersensitivity_rea | 2.15746764 |
15 | MP0005174_abnormal_tail_pigmentation | 2.11711248 |
16 | MP0006082_CNS_inflammation | 2.09246504 |
17 | MP0005000_abnormal_immune_tolerance | 2.07677351 |
18 | MP0010234_abnormal_vibrissa_follicle | 1.99206856 |
19 | MP0002452_abnormal_antigen_presenting | 1.96312209 |
20 | MP0010307_abnormal_tumor_latency | 1.94949784 |
21 | MP0003950_abnormal_plasma_membrane | 1.82055907 |
22 | MP0009785_altered_susceptibility_to | 1.81915383 |
23 | MP0005025_abnormal_response_to | 1.79521210 |
24 | MP0003448_altered_tumor_morphology | 1.74974200 |
25 | MP0003806_abnormal_nucleotide_metabolis | 1.71993283 |
26 | MP0003566_abnormal_cell_adhesion | 1.70108169 |
27 | MP0002405_respiratory_system_inflammati | 1.68946340 |
28 | MP0005464_abnormal_platelet_physiology | 1.62153363 |
29 | MP0003300_gastrointestinal_ulcer | 1.62020294 |
30 | MP0001790_abnormal_immune_system | 1.61764711 |
31 | MP0005387_immune_system_phenotype | 1.61764711 |
32 | MP0001819_abnormal_immune_cell | 1.60834407 |
33 | MP0002420_abnormal_adaptive_immunity | 1.58766583 |
34 | MP0001533_abnormal_skeleton_physiology | 1.58130743 |
35 | MP0002723_abnormal_immune_serum | 1.57134636 |
36 | MP0002139_abnormal_hepatobiliary_system | 1.51378007 |
37 | MP0001853_heart_inflammation | 1.50571741 |
38 | MP0000015_abnormal_ear_pigmentation | 1.50410025 |
39 | MP0003724_increased_susceptibility_to | 1.49648112 |
40 | MP0010352_gastrointestinal_tract_polyps | 1.49275178 |
41 | MP0001800_abnormal_humoral_immune | 1.48701952 |
42 | MP0000858_altered_metastatic_potential | 1.47544776 |
43 | MP0003279_aneurysm | 1.47250384 |
44 | MP0005076_abnormal_cell_differentiation | 1.44010977 |
45 | MP0002998_abnormal_bone_remodeling | 1.42416231 |
46 | MP0000343_altered_response_to | 1.42407606 |
47 | MP0004947_skin_inflammation | 1.42128035 |
48 | MP0005671_abnormal_response_to | 1.42003271 |
49 | MP0002166_altered_tumor_susceptibility | 1.40119498 |
50 | MP0006054_spinal_hemorrhage | 1.39906651 |
51 | MP0000685_abnormal_immune_system | 1.38732950 |
52 | MP0002006_tumorigenesis | 1.38311989 |
53 | MP0005451_abnormal_body_composition | 1.37231833 |
54 | MP0005379_endocrine/exocrine_gland_phen | 1.35013821 |
55 | MP0000371_diluted_coat_color | 1.34367963 |
56 | MP0005075_abnormal_melanosome_morpholog | 1.31194085 |
57 | MP0000372_irregular_coat_pigmentation | 1.30060974 |
58 | MP0009278_abnormal_bone_marrow | 1.27578444 |
59 | MP0003656_abnormal_erythrocyte_physiolo | 1.25445387 |
60 | MP0003329_amyloid_beta_deposits | 1.25236238 |
61 | MP0001845_abnormal_inflammatory_respons | 1.21767651 |
62 | MP0003705_abnormal_hypodermis_morpholog | 1.20971158 |
63 | MP0000490_abnormal_crypts_of | 1.20963759 |
64 | MP0003195_calcinosis | 1.20863269 |
65 | MP0003091_abnormal_cell_migration | 1.15434607 |
66 | MP0003183_abnormal_peptide_metabolism | 1.15015712 |
67 | MP0010155_abnormal_intestine_physiology | 1.14500371 |
68 | MP0005023_abnormal_wound_healing | 1.13841999 |
69 | MP0009764_decreased_sensitivity_to | 1.13393580 |
70 | MP0000639_abnormal_adrenal_gland | 1.11057846 |
71 | MP0009333_abnormal_splenocyte_physiolog | 1.10247891 |
72 | MP0004808_abnormal_hematopoietic_stem | 1.09985383 |
73 | MP0004510_myositis | 1.09209734 |
74 | MP0005171_absent_coat_pigmentation | 1.08142301 |
75 | MP0003763_abnormal_thymus_physiology | 1.07256182 |
76 | MP0005647_abnormal_sex_gland | 1.06610333 |
77 | MP0005390_skeleton_phenotype | 1.05071830 |
78 | * MP0000716_abnormal_immune_system | 1.04928538 |
79 | MP0003828_pulmonary_edema | 1.04677180 |
80 | MP0008875_abnormal_xenobiotic_pharmacok | 1.03596585 |
81 | MP0004883_abnormal_blood_vessel | 1.03107960 |
82 | MP0010678_abnormal_skin_adnexa | 1.02496622 |
83 | MP0002909_abnormal_adrenal_gland | 1.02184046 |
84 | MP0001851_eye_inflammation | 1.01126587 |
85 | MP0002398_abnormal_bone_marrow | 0.99418183 |
86 | MP0000465_gastrointestinal_hemorrhage | 0.98837775 |
87 | MP0000689_abnormal_spleen_morphology | 0.98110135 |
88 | MP0008007_abnormal_cellular_replicative | 0.96441729 |
89 | MP0000767_abnormal_smooth_muscle | 0.95773972 |
90 | MP0003693_abnormal_embryo_hatching | 0.95345693 |
91 | MP0005164_abnormal_response_to | 0.92991608 |
92 | MP0001915_intracranial_hemorrhage | 0.92563728 |
93 | MP0002090_abnormal_vision | 0.92344975 |
94 | * MP0000647_abnormal_sebaceous_gland | 0.92032431 |
95 | MP0004381_abnormal_hair_follicle | 0.90987930 |
96 | * MP0002722_abnormal_immune_system | 0.90681405 |
97 | MP0003191_abnormal_cellular_cholesterol | 0.89969156 |
98 | MP0008004_abnormal_stomach_pH | 0.89908861 |
99 | MP0009384_cardiac_valve_regurgitation | 0.89659273 |
100 | * MP0002429_abnormal_blood_cell | 0.86936595 |
101 | MP0005365_abnormal_bile_salt | 0.86717795 |
102 | MP0005310_abnormal_salivary_gland | 0.85759064 |
103 | MP0003795_abnormal_bone_structure | 0.84761931 |
104 | MP0002933_joint_inflammation | 0.84719730 |
105 | MP0001175_abnormal_lung_morphology | 0.84645089 |
106 | MP0005166_decreased_susceptibility_to | 0.83652470 |
107 | MP0008260_abnormal_autophagy | 0.83407709 |
108 | MP0001243_abnormal_dermal_layer | 0.82882474 |
109 | MP0003453_abnormal_keratinocyte_physiol | 0.82354226 |
110 | MP0003011_delayed_dark_adaptation | 0.81307717 |
111 | MP0005165_increased_susceptibility_to | 0.80978127 |
112 | MP0002133_abnormal_respiratory_system | 0.80585033 |
113 | MP0005388_respiratory_system_phenotype | 0.80585033 |
114 | MP0008469_abnormal_protein_level | 0.80355185 |
115 | MP0002075_abnormal_coat/hair_pigmentati | 0.80334530 |
116 | MP0003690_abnormal_glial_cell | 0.78778951 |
117 | MP0003075_altered_response_to | 0.78429562 |
118 | MP0001186_pigmentation_phenotype | 0.78255785 |
119 | MP0000733_abnormal_muscle_development | 0.78234186 |
120 | MP0005197_abnormal_uvea_morphology | 0.78056400 |
121 | MP0002277_abnormal_respiratory_mucosa | 0.77743346 |
122 | MP0004272_abnormal_basement_membrane | 0.77380430 |
123 | MP0002095_abnormal_skin_pigmentation | 0.77015600 |
124 | MP0009763_increased_sensitivity_to | 0.76785766 |
125 | MP0001545_abnormal_hematopoietic_system | 0.76385311 |
126 | MP0005397_hematopoietic_system_phenotyp | 0.76385311 |
127 | MP0002295_abnormal_pulmonary_circulatio | 0.76045561 |
128 | MP0005275_abnormal_skin_tensile | 0.75892429 |
129 | MP0000609_abnormal_liver_physiology | 0.75592017 |
130 | MP0000383_abnormal_hair_follicle | 0.75486889 |
131 | MP0005408_hypopigmentation | 0.75141043 |
132 | MP0001661_extended_life_span | 0.74873482 |
133 | MP0002877_abnormal_melanocyte_morpholog | 0.74652354 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 5.97782250 |
2 | Eczematoid dermatitis (HP:0000976) | 5.36198850 |
3 | Recurrent bacterial skin infections (HP:0005406) | 5.11781132 |
4 | Increased cerebral lipofuscin (HP:0011813) | 4.80679002 |
5 | Vacuolated lymphocytes (HP:0001922) | 4.45485051 |
6 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.33268331 |
7 | Abnormality of macrophages (HP:0004311) | 4.27008009 |
8 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.04262771 |
9 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.60172325 |
10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.60172325 |
11 | Abnormality of glycolipid metabolism (HP:0010969) | 3.60172325 |
12 | Gingivitis (HP:0000230) | 3.40862658 |
13 | Mediastinal lymphadenopathy (HP:0100721) | 3.38667790 |
14 | Interstitial pulmonary disease (HP:0006530) | 3.38174266 |
15 | Disinhibition (HP:0000734) | 3.20209054 |
16 | Obstructive lung disease (HP:0006536) | 2.98379297 |
17 | Chronic obstructive pulmonary disease (HP:0006510) | 2.98379297 |
18 | Periodontitis (HP:0000704) | 2.97171301 |
19 | Dysostosis multiplex (HP:0000943) | 2.96771217 |
20 | Autoimmune thrombocytopenia (HP:0001973) | 2.90929246 |
21 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.90682740 |
22 | Osteolytic defects of the hand bones (HP:0009699) | 2.90682740 |
23 | Recurrent skin infections (HP:0001581) | 2.83918338 |
24 | Prostate neoplasm (HP:0100787) | 2.81771968 |
25 | Agnosia (HP:0010524) | 2.70762030 |
26 | Absent frontal sinuses (HP:0002688) | 2.67373871 |
27 | Prolonged neonatal jaundice (HP:0006579) | 2.65643094 |
28 | Recurrent fungal infections (HP:0002841) | 2.63465720 |
29 | Myositis (HP:0100614) | 2.62596450 |
30 | Hematochezia (HP:0002573) | 2.56957623 |
31 | Neurofibrillary tangles (HP:0002185) | 2.53928027 |
32 | Orchitis (HP:0100796) | 2.48276940 |
33 | Osteomyelitis (HP:0002754) | 2.47763369 |
34 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.47598859 |
35 | Mucopolysacchariduria (HP:0008155) | 2.47598859 |
36 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.46705982 |
37 | T lymphocytopenia (HP:0005403) | 2.40946785 |
38 | Thick nail (HP:0001805) | 2.40299066 |
39 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.37677959 |
40 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.37677959 |
41 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.37677959 |
42 | Basal ganglia calcification (HP:0002135) | 2.36807138 |
43 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.35597955 |
44 | Xanthomatosis (HP:0000991) | 2.30723996 |
45 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.29918420 |
46 | Retrobulbar optic neuritis (HP:0100654) | 2.29581083 |
47 | Optic neuritis (HP:0100653) | 2.29581083 |
48 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.27036490 |
49 | Spondylolisthesis (HP:0003302) | 2.26353987 |
50 | Cellulitis (HP:0100658) | 2.24338029 |
51 | Axonal loss (HP:0003447) | 2.24245620 |
52 | Increased CSF protein (HP:0002922) | 2.23365596 |
53 | Abnormality of T cell number (HP:0011839) | 2.22739165 |
54 | Global brain atrophy (HP:0002283) | 2.22032983 |
55 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.21872820 |
56 | Vertebral compression fractures (HP:0002953) | 2.18585290 |
57 | Abnormality of the frontal sinuses (HP:0002687) | 2.18139512 |
58 | Premature loss of primary teeth (HP:0006323) | 2.17444786 |
59 | Mitral stenosis (HP:0001718) | 2.17206921 |
60 | Skin nodule (HP:0200036) | 2.16171318 |
61 | Pustule (HP:0200039) | 2.13092493 |
62 | Protuberant abdomen (HP:0001538) | 2.10927215 |
63 | Abnormality of the periventricular white matter (HP:0002518) | 2.08166470 |
64 | Recurrent pneumonia (HP:0006532) | 2.07277298 |
65 | Systemic lupus erythematosus (HP:0002725) | 2.06931474 |
66 | Loss of speech (HP:0002371) | 2.05877224 |
67 | Poor head control (HP:0002421) | 2.03074163 |
68 | Renal salt wasting (HP:0000127) | 2.02812405 |
69 | Cervical subluxation (HP:0003308) | 2.02675429 |
70 | Cerebral inclusion bodies (HP:0100314) | 2.02603936 |
71 | Cheilitis (HP:0100825) | 2.01863199 |
72 | Cutaneous melanoma (HP:0012056) | 1.99880418 |
73 | Progressive neurologic deterioration (HP:0002344) | 1.98331893 |
74 | Amyloidosis (HP:0011034) | 1.95688887 |
75 | Cerebral aneurysm (HP:0004944) | 1.93240410 |
76 | Bone pain (HP:0002653) | 1.90565554 |
77 | Epidermoid cyst (HP:0200040) | 1.90365345 |
78 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.90069302 |
79 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.89607839 |
80 | Cardiomegaly (HP:0001640) | 1.88778802 |
81 | Recurrent viral infections (HP:0004429) | 1.87965578 |
82 | Pathologic fracture (HP:0002756) | 1.87256771 |
83 | Spinal cord lesions (HP:0100561) | 1.85882474 |
84 | Syringomyelia (HP:0003396) | 1.85882474 |
85 | Retinal atrophy (HP:0001105) | 1.85255261 |
86 | Stomatitis (HP:0010280) | 1.84873937 |
87 | Subacute progressive viral hepatitis (HP:0006572) | 1.84553581 |
88 | Metaphyseal irregularity (HP:0003025) | 1.83305377 |
89 | Ovoid vertebral bodies (HP:0003300) | 1.83098091 |
90 | Myocardial infarction (HP:0001658) | 1.80644697 |
91 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.79280279 |
92 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.77757250 |
93 | Recurrent cutaneous fungal infections (HP:0011370) | 1.77757250 |
94 | Asymmetric septal hypertrophy (HP:0001670) | 1.77147436 |
95 | Leukocytosis (HP:0001974) | 1.76835124 |
96 | Premature rupture of membranes (HP:0001788) | 1.76303040 |
97 | Pulmonary infiltrates (HP:0002113) | 1.76284246 |
98 | Abnormality of the nasal septum (HP:0000419) | 1.72613570 |
99 | Abnormality of the lumbar spine (HP:0100712) | 1.71765597 |
100 | Mutism (HP:0002300) | 1.71133370 |
101 | Hemoptysis (HP:0002105) | 1.70648459 |
102 | Esophageal neoplasm (HP:0100751) | 1.70398284 |
103 | Neoplasm of head and neck (HP:0012288) | 1.70398284 |
104 | Decreased circulating renin level (HP:0003351) | 1.70374444 |
105 | Tetraparesis (HP:0002273) | 1.70073903 |
106 | Recurrent lower respiratory tract infections (HP:0002783) | 1.70051770 |
107 | Coarse hair (HP:0002208) | 1.68688095 |
108 | Nuclear cataract (HP:0100018) | 1.68048068 |
109 | Hepatosplenomegaly (HP:0001433) | 1.67938916 |
110 | Eosinophilia (HP:0001880) | 1.67767657 |
111 | Acrocyanosis (HP:0001063) | 1.67601735 |
112 | Ocular albinism (HP:0001107) | 1.66313478 |
113 | Meningitis (HP:0001287) | 1.64863649 |
114 | Short nail (HP:0001799) | 1.63246599 |
115 | Pulmonary fibrosis (HP:0002206) | 1.63009799 |
116 | Increased serum ferritin (HP:0003281) | 1.62619668 |
117 | Urticaria (HP:0001025) | 1.62584808 |
118 | Glomerulopathy (HP:0100820) | 1.62227812 |
119 | Mucosal telangiectasiae (HP:0100579) | 1.62224941 |
120 | Chronic diarrhea (HP:0002028) | 1.61668906 |
121 | Diminished motivation (HP:0000745) | 1.59847220 |
122 | Spontaneous hematomas (HP:0007420) | 1.59677268 |
123 | Orthostatic hypotension (HP:0001278) | 1.59549101 |
124 | Abnormality of primary teeth (HP:0006481) | 1.55692488 |
125 | Gonadotropin excess (HP:0000837) | 1.55319610 |
126 | Conjunctival telangiectasia (HP:0000524) | 1.54875574 |
127 | Arterial thrombosis (HP:0004420) | 1.54184528 |
128 | J-shaped sella turcica (HP:0002680) | 1.53947535 |
129 | Albinism (HP:0001022) | 1.53525488 |
130 | Broad face (HP:0000283) | 1.50945667 |
131 | Vasculitis (HP:0002633) | 1.49675324 |
132 | Thoracic kyphosis (HP:0002942) | 1.48429794 |
133 | Deformed sella turcica (HP:0002681) | 1.48361239 |
134 | Apathy (HP:0000741) | 1.47714016 |
135 | Sepsis (HP:0100806) | 1.47344039 |
136 | Persistence of primary teeth (HP:0006335) | 1.46915401 |
137 | Upper motor neuron abnormality (HP:0002127) | 1.46442358 |
138 | Skin ulcer (HP:0200042) | 1.46030253 |
139 | Selective tooth agenesis (HP:0001592) | 1.45606950 |
140 | Glomerulonephritis (HP:0000099) | 1.45170534 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PBK | 3.08294874 |
2 | IRAK3 | 2.69425278 |
3 | MAP3K14 | 2.68416861 |
4 | PDK2 | 2.64239350 |
5 | IRAK4 | 2.49490826 |
6 | FRK | 2.47431170 |
7 | RIPK4 | 2.37182292 |
8 | KIT | 2.28387937 |
9 | BLK | 2.17844572 |
10 | NEK9 | 2.10817944 |
11 | STK10 | 2.05931549 |
12 | TBK1 | 1.97492214 |
13 | GRK7 | 1.97054049 |
14 | TYK2 | 1.88888337 |
15 | BMPR2 | 1.81596637 |
16 | RPS6KA4 | 1.79556838 |
17 | TGFBR2 | 1.77329254 |
18 | MAP4K1 | 1.76061048 |
19 | CDK12 | 1.71063152 |
20 | MKNK1 | 1.69180432 |
21 | MAP3K13 | 1.67318263 |
22 | TRPM7 | 1.56788593 |
23 | CAMK1D | 1.51079409 |
24 | ZAP70 | 1.50640071 |
25 | SCYL2 | 1.49558543 |
26 | CDK6 | 1.47281682 |
27 | DDR2 | 1.46711373 |
28 | JAK3 | 1.44483104 |
29 | MKNK2 | 1.44316306 |
30 | TESK1 | 1.44287021 |
31 | LRRK2 | 1.41695918 |
32 | TTN | 1.41338168 |
33 | NME2 | 1.40495513 |
34 | IKBKB | 1.38702937 |
35 | TEC | 1.38663140 |
36 | PAK4 | 1.34870399 |
37 | TXK | 1.31095979 |
38 | YES1 | 1.29937839 |
39 | ERBB4 | 1.28429354 |
40 | TAOK3 | 1.26612945 |
41 | STK4 | 1.26090683 |
42 | PIM1 | 1.25627313 |
43 | BMX | 1.24123817 |
44 | HCK | 1.17301565 |
45 | STK3 | 1.15921383 |
46 | TESK2 | 1.14434225 |
47 | AKT3 | 1.14393805 |
48 | IKBKE | 1.13329882 |
49 | CHUK | 1.13284021 |
50 | JAK1 | 1.12504810 |
51 | CSF1R | 1.12154070 |
52 | PTK6 | 1.11105141 |
53 | MST1R | 1.10574246 |
54 | MAP3K2 | 1.08982857 |
55 | EIF2AK3 | 1.08342932 |
56 | FER | 1.07682534 |
57 | MARK3 | 1.06783976 |
58 | PKN2 | 1.04599190 |
59 | BTK | 1.04181572 |
60 | MAP3K3 | 1.01596378 |
61 | ERBB3 | 0.99733160 |
62 | PDGFRB | 0.98946363 |
63 | LYN | 0.97991534 |
64 | EPHA3 | 0.97268778 |
65 | FGFR3 | 0.97049015 |
66 | MELK | 0.96557042 |
67 | NUAK1 | 0.96175166 |
68 | PIM2 | 0.94679699 |
69 | BRD4 | 0.93172758 |
70 | CSK | 0.92545759 |
71 | EPHB1 | 0.92470757 |
72 | EIF2AK2 | 0.91625505 |
73 | ITK | 0.90580407 |
74 | MST4 | 0.90144329 |
75 | CLK1 | 0.88505917 |
76 | CDC42BPA | 0.85849843 |
77 | CDK7 | 0.85828454 |
78 | ADRBK2 | 0.85335030 |
79 | RIPK1 | 0.84917623 |
80 | NEK2 | 0.84221813 |
81 | LCK | 0.83427433 |
82 | MAP3K1 | 0.82516347 |
83 | PDK1 | 0.81232430 |
84 | SYK | 0.78713918 |
85 | PDPK1 | 0.78523560 |
86 | MAP2K3 | 0.78055852 |
87 | FGR | 0.77704748 |
88 | STK24 | 0.76966375 |
89 | ERN1 | 0.76897733 |
90 | ZAK | 0.76357079 |
91 | PLK4 | 0.73212221 |
92 | CDC7 | 0.72978753 |
93 | PRKAA2 | 0.72562384 |
94 | ABL1 | 0.69707932 |
95 | PDGFRA | 0.67708064 |
96 | IRAK1 | 0.66351215 |
97 | ACVR1B | 0.65631730 |
98 | ABL2 | 0.65168714 |
99 | TRIB3 | 0.65053689 |
100 | MAPK11 | 0.64009759 |
101 | MAP3K5 | 0.62345900 |
102 | MAP3K8 | 0.62077794 |
103 | NEK6 | 0.60661246 |
104 | EGFR | 0.60428052 |
105 | GSK3A | 0.59730162 |
106 | LIMK1 | 0.58062867 |
107 | PTK2B | 0.56425628 |
108 | ICK | 0.55976250 |
109 | BRSK2 | 0.55151008 |
110 | CAMK1G | 0.54447162 |
111 | PRKCD | 0.53310935 |
112 | SIK3 | 0.53109179 |
113 | FLT3 | 0.52379158 |
114 | PIK3CG | 0.51197310 |
115 | JAK2 | 0.50008974 |
116 | AURKB | 0.49733297 |
117 | NLK | 0.48109274 |
118 | CDK4 | 0.47269750 |
119 | ATR | 0.46928308 |
120 | MAP3K10 | 0.46703529 |
121 | PRPF4B | 0.46506968 |
122 | FGFR4 | 0.46347913 |
123 | FGFR1 | 0.43883004 |
124 | MAPKAPK2 | 0.43836968 |
125 | RPS6KA6 | 0.43373604 |
126 | SGK3 | 0.43027397 |
127 | IGF1R | 0.42883864 |
128 | CAMKK2 | 0.42640940 |
129 | MOS | 0.42598554 |
130 | TGFBR1 | 0.42144680 |
131 | BMPR1B | 0.41272883 |
132 | TAOK2 | 0.39672114 |
133 | FES | 0.39102982 |
134 | MAP3K12 | 0.37793169 |
135 | MATK | 0.36932565 |
136 | MAPK7 | 0.35754578 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Lysosome_Homo sapiens_hsa04142 | 2.79407637 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.58685863 |
3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.42156193 |
4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.14085909 |
5 | Phagosome_Homo sapiens_hsa04145 | 2.06750159 |
6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.98187331 |
7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.98153673 |
8 | Malaria_Homo sapiens_hsa05144 | 1.91185638 |
9 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.89885763 |
10 | Legionellosis_Homo sapiens_hsa05134 | 1.88918173 |
11 | Tuberculosis_Homo sapiens_hsa05152 | 1.87904654 |
12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.84322487 |
13 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.79887944 |
14 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.75029665 |
15 | Pertussis_Homo sapiens_hsa05133 | 1.64560717 |
16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.59020056 |
17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.55455011 |
18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.53986124 |
19 | Measles_Homo sapiens_hsa05162 | 1.52734172 |
20 | Apoptosis_Homo sapiens_hsa04210 | 1.49240928 |
21 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.48637115 |
22 | Salmonella infection_Homo sapiens_hsa05132 | 1.47494330 |
23 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.44385365 |
24 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.40355354 |
25 | Shigellosis_Homo sapiens_hsa05131 | 1.39067455 |
26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.33778736 |
27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.32124338 |
28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.28857507 |
29 | Influenza A_Homo sapiens_hsa05164 | 1.27997147 |
30 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.27394658 |
31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.26114623 |
32 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.25611164 |
33 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.23257942 |
34 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.22314717 |
35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.20552863 |
36 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.19826405 |
37 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.18947273 |
38 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.18606178 |
39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.17878548 |
40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.12909707 |
41 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.10699449 |
42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10391176 |
43 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.08177052 |
44 | Hepatitis B_Homo sapiens_hsa05161 | 1.08143003 |
45 | Asthma_Homo sapiens_hsa05310 | 1.07344490 |
46 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.07079565 |
47 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.06557378 |
48 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.05831306 |
49 | Adherens junction_Homo sapiens_hsa04520 | 1.03863676 |
50 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03552011 |
51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.03267646 |
52 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.02780887 |
53 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.02368439 |
54 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.02270064 |
55 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.01053976 |
56 | Allograft rejection_Homo sapiens_hsa05330 | 0.96940956 |
57 | Viral myocarditis_Homo sapiens_hsa05416 | 0.95839985 |
58 | Mineral absorption_Homo sapiens_hsa04978 | 0.94988304 |
59 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.93756070 |
60 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.92432881 |
61 | * Steroid biosynthesis_Homo sapiens_hsa00100 | 0.89399402 |
62 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.89081027 |
63 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.88966401 |
64 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.88375929 |
65 | Amoebiasis_Homo sapiens_hsa05146 | 0.88212251 |
66 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.87368775 |
67 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.84565681 |
68 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.84448735 |
69 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.84254736 |
70 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.80197124 |
71 | Focal adhesion_Homo sapiens_hsa04510 | 0.80142486 |
72 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.79899445 |
73 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.78267202 |
74 | Homologous recombination_Homo sapiens_hsa03440 | 0.77708357 |
75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77370278 |
76 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.76485450 |
77 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.76021103 |
78 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.75473707 |
79 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.75113166 |
80 | DNA replication_Homo sapiens_hsa03030 | 0.72834070 |
81 | Prostate cancer_Homo sapiens_hsa05215 | 0.72529471 |
82 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.72474038 |
83 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71261506 |
84 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.71231493 |
85 | Platelet activation_Homo sapiens_hsa04611 | 0.70153073 |
86 | Galactose metabolism_Homo sapiens_hsa00052 | 0.70029048 |
87 | Hepatitis C_Homo sapiens_hsa05160 | 0.69996139 |
88 | Cell cycle_Homo sapiens_hsa04110 | 0.69040607 |
89 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68284358 |
90 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.66457654 |
91 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.65475618 |
92 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.64118250 |
93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.63084043 |
94 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.61931099 |
95 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.61647429 |
96 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.60135043 |
97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58966161 |
98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.58806798 |
99 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.57911804 |
100 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.57676822 |
101 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.55500419 |
102 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52169514 |
103 | Base excision repair_Homo sapiens_hsa03410 | 0.51331983 |
104 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.50455837 |
105 | Endocytosis_Homo sapiens_hsa04144 | 0.48317899 |
106 | Melanoma_Homo sapiens_hsa05218 | 0.48043243 |
107 | Pathways in cancer_Homo sapiens_hsa05200 | 0.47448297 |
108 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47144881 |
109 | Colorectal cancer_Homo sapiens_hsa05210 | 0.46288622 |
110 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.46240757 |
111 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.45574658 |
112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45484342 |
113 | Bladder cancer_Homo sapiens_hsa05219 | 0.44866610 |
114 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44781376 |
115 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.42777862 |
116 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.42206015 |
117 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.41975098 |
118 | Mismatch repair_Homo sapiens_hsa03430 | 0.41060395 |
119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39481923 |
120 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39330105 |
121 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.38796450 |
122 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.29966363 |
123 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29722468 |
124 | Insulin resistance_Homo sapiens_hsa04931 | 0.28934430 |
125 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28852976 |
126 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.26835019 |
127 | Prion diseases_Homo sapiens_hsa05020 | 0.23691164 |